CPIG
UTHR icon

Chicago Partners Investment Group’s United Therapeutics UTHR Stock Holding History

Chicago Partners Investment Group’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$624K Buy
1,179
+20
+2% +$11.3K 0.01% 865
2026
Q1 		$666K Buy
1,159
+153
+15% +$76.2K 0.01% 729
2025
Q4 		$472K Buy
+1,006
New +$468K 0.01% 800

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Chicago Partners Investment Group's UTHR Position: Q2 2026 in Review

Chicago Partners Investment Group increased its United Therapeutics (UTHR) stake by 1.7% in Q2 2026, buying an estimated $11.3K and bringing the position to 1,179 shares worth $624K. The position accounts for 0.01% of the portfolio, ranked #865.

Chicago Partners Investment Group first reported a position in UTHR in Q4 2025 and has held it in 3 quarters since. The position peaked at $666K in Q1 2026. 884 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Chicago Partners Investment Group held 1,179 shares of United Therapeutics worth $624K as of Q2 2026.
  • Chicago Partners Investment Group bought 20 United Therapeutics shares in Q2 2026, an estimated $11.3K.
  • United Therapeutics made up 0.01% of Chicago Partners Investment Group's portfolio in Q2 2026, its #865 holding.
  • Chicago Partners Investment Group first reported a position in United Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • Chicago Partners Investment Group's United Therapeutics position peaked at $666K in Q1 2026.
  • 884 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Chicago Partners Investment Group's 13F filing for Q2 2026, filed 30 Jul 2026.